Epidarex Capital Partners Limited (formerly Rock Spring Ventures) is an Edinburgh based venture capital firm investing in the life sciences and health technology sector in United States and United Kingdom. It prefers innovations from the educational sectors like universities. The company focuses on biotechnology, medical devices and pharmaceuticals, personalized medicine and diagnostics, and healthcare IT and services. As of 2019, the company has invested 23 times in 12 portfolio companies with three successful exits.
Funding Rounds Participated In
January 7, 2021
/PRNewswire/ -- Theolytics, a UK biotech harnessing viruses to combat cancer, today announced the closing of a US $6.8 million (UK £5 million) Series A round....
June 22, 2020
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
June 22, 2020
Click HERE to find out ⭐ The British Business Bank Commits £50 million to New Epidarex Capital III UK LP fund. | Crowdfund Insider: Global Fintech News, including Crowdfunding, Blockchain and more.
Epidarex Capital Partners LLC
137a George Street Edinburgh United Kingdom, EH2 4JY
7910 Woodmont Avenue Suite 1210 Bethesda, Maryland 20814
Venture Capital Firm attributes
Company Operating Status